Cargando…

T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients

Detalles Bibliográficos
Autores principales: Övergaard, Ninja, Lia, Kjersti, Asdahl, Peter, Wikman, Per, Glimelius, Ingrid, Lagerlöf., Ingemar, Johansson, Ann-Sofie, Hansson, Lotta, Enblad, Gunilla, Linderoth, Johan, Goldkuhl, Christina, Fosså, Alexander, Kamper, Peter, Molin, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642063/
http://dx.doi.org/10.1097/01.HS9.0000890896.83681.49
_version_ 1784826223047737344
author Övergaard, Ninja
Lia, Kjersti
Asdahl, Peter
Wikman, Per
Glimelius, Ingrid
Lagerlöf., Ingemar
Johansson, Ann-Sofie
Hansson, Lotta
Enblad, Gunilla
Linderoth, Johan
Goldkuhl, Christina
Fosså, Alexander
Kamper, Peter
Molin, Daniel
author_facet Övergaard, Ninja
Lia, Kjersti
Asdahl, Peter
Wikman, Per
Glimelius, Ingrid
Lagerlöf., Ingemar
Johansson, Ann-Sofie
Hansson, Lotta
Enblad, Gunilla
Linderoth, Johan
Goldkuhl, Christina
Fosså, Alexander
Kamper, Peter
Molin, Daniel
author_sort Övergaard, Ninja
collection PubMed
description
format Online
Article
Text
id pubmed-9642063
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-96420632022-11-14 T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients Övergaard, Ninja Lia, Kjersti Asdahl, Peter Wikman, Per Glimelius, Ingrid Lagerlöf., Ingemar Johansson, Ann-Sofie Hansson, Lotta Enblad, Gunilla Linderoth, Johan Goldkuhl, Christina Fosså, Alexander Kamper, Peter Molin, Daniel Hemasphere Older & Frail Patients Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9642063/ http://dx.doi.org/10.1097/01.HS9.0000890896.83681.49 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Older & Frail Patients
Övergaard, Ninja
Lia, Kjersti
Asdahl, Peter
Wikman, Per
Glimelius, Ingrid
Lagerlöf., Ingemar
Johansson, Ann-Sofie
Hansson, Lotta
Enblad, Gunilla
Linderoth, Johan
Goldkuhl, Christina
Fosså, Alexander
Kamper, Peter
Molin, Daniel
T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
title T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
title_full T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
title_fullStr T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
title_full_unstemmed T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
title_short T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
title_sort t082: avd - a possible golden standard in the first-line treatment of older classical hodgkin lymphoma patients
topic Older & Frail Patients
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642063/
http://dx.doi.org/10.1097/01.HS9.0000890896.83681.49
work_keys_str_mv AT overgaardninja t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT liakjersti t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT asdahlpeter t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT wikmanper t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT glimeliusingrid t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT lagerlofingemar t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT johanssonannsofie t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT hanssonlotta t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT enbladgunilla t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT linderothjohan t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT goldkuhlchristina t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT fossaalexander t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT kamperpeter t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients
AT molindaniel t082avdapossiblegoldenstandardinthefirstlinetreatmentofolderclassicalhodgkinlymphomapatients